Circadian Rhythm Sleep Disorders Market – Global Industry Analysis and Forecast(2023-2029)

Circadian Rhythm Sleep Disorders Market is expected to grow at a CAGR of 5.33% during the forecast period. Global Circadian Rhythm Sleep Disorders Market is expected to reach US$ 1.28 Bn. by 2029.

Circadian Rhythm Sleep Disorders Market Overview

A disruption in sleep patterns that affects the body's basic functions is known as circadian rhythm sleep disruption. Some of the symptoms of this sleep disorder include insomnia, excessive sleepiness, and restlessness. The biological clock, also known as circadian rhythms, controls everyday processes like body temperature, alertness, hormone secretion, and sleep patterns. Circadian rhythm has been related to a variety of diseases. These disorders can have detrimental psychological and functional effects. As a result of the effect of western culture, urbanization, and industrialization, those working in corporate environments are more prone to get these diseases. As a result, demand for its diagnosis has increased. Circadian Rhythm Sleep Disorders MarketTo know about the Research Methodology :- Request Free Sample Report

Global Circadian Rhythm Sleep Disorders Market Dynamics

The growing frequency of psychological difficulties such as anxiety, hypertension, depression, and other sleep-related illnesses is driving the worldwide sleep disorder market. According to the World Health Organization (WHO), depression is a prevalent ailment that affects over 264 million people and can lead to sleep disorders or other major health problems in the long term. One of the main reasons in the sleep disorder market is the incidence of depression. There is an accumulating body of research, primarily from Western countries, demonstrating a decline in average sleep duration and a larger prevalence of insomnia. According to national surveys conducted in Canada and the United States, more than 20% of individuals suffer from insomnia, and this figure is consistent with regular occurrences of short sleep duration in industrialized countries. These diseases have a huge impact on society as a whole, imposing a large burden in terms of morbidity and death, as well as cost implications, and all of this negative pushes society to rely on sleep disorder therapies, propelling the market globally. According to a sleep heart study, those who had a history of insomnia or poor sleep had a 29 % increased risk of cardiovascular disease (CVD). These kinds of figures encourage those suffering from sleep disorders to seek expert assistance, hence raising the market's demand. Despite this, the growing elderly population throughout the globe is expected to provide new potential for market growth during the forecast period. However, a lack of understanding about the primary concerns linked to circadian rhythm sleep disorders in developing countries may hamper the growth of the circadian rhythm sleep disorders market. Furthermore, disregard for pharmacological side effects and sleep issues might impede the growth of the circadian rhythm sleep disorders market. Growing Elderly Population Boosts the Market's Growth Some of the primary reasons driving the worldwide growth of the CRSD market are the growing elderly population and the rising frequency of chronic illnesses. The world's population is aging, particularly in industrialized countries such as the United States, Europe, and Japan. The global elderly population is expected to increase from 760 million (11%) to 1 billion by 2029. (2050). As a result, the growing elderly population boosts the market's growth.

Global Circadian Rhythm Sleep Disorders Market Segment Analysis

By Disorder, the DSPS segment accounted for more than 50.2 % of the total circadian rhythm sleep disorders market by revenue in 2022. Young individuals are the most commonly affected age group by DSPS, though it can affect anyone at any age. The rising usage of Melatonin Recipient Aguilant is expected to stimulate the growth of the DSPS type segment during the forecast due to benefits such as decreased side effects and enhanced efficacy. By End User, the global market for circadian rhythm sleep disorders is divided into four segments: home care settings, wellness centres and spas, sleep testing facilities, and specialist clinics. The Specialty Clinic category is projected to develop in the worldwide circadian sleeping disorders market at the highest CAGR of nearly to xx percent of all end users. This assists you to get the greatest outcome for your therapy and therapy. Hospital clinics provide a vital connection between the hospital and community therapy.

Global Circadian Rhythm Sleep Disorders Market Regional Insights

North America is expected to dominate the global sleep disorder market with the highest revenue share during the forecast period. The advanced healthcare infrastructure increased awareness of the negative effects of sleep disorders, and an increase in the number of mental problems occurring as a result of sleep disorder problems in this region is driving the market growth. For example, more than 65 % of Americans aged 20 to 59 reported experiencing regular sleeping issues. According to certain figures, 50-70 million US individuals suffer from sleep disorders, 48 % have a snoring issue, 4.7 % have fallen asleep while driving at least once a month, and roughly 25 million U.S. individuals have obstructive sleep apnea. According to research, roughly 66 % of patients in the United States have a favorable impression of CPAP (Continuous Positive Airway Pressure), which aids in the treatment of sleep disorders, and these sorts of therapies fuel market growth in this region. Europe is the second-largest market, owing to the region's growing senior population and well-developed healthcare facilities. According to the European Commission, Europe's old-age dependence ratio (those aged 65 and over compared to those aged 15 to 64) is anticipated to rise from 29.6% in 2021 to 51.2 percent in 2029, worsening sleep problem instances in the future. Asia-Pacific is expected to have the largest growth rate over the forecast period due to the region's large population, increased awareness of sleep disorders, changing lifestyle preferences, and improving healthcare infrastructure. The objective of the report is to present a comprehensive analysis of the Global Circadian Rhythm Sleep Disorders Market to the stakeholders in the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Circadian Rhythm Sleep Disorders Market dynamics, structure by analyzing the market segments and project the Global Circadian Rhythm Sleep Disorders Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Circadian Rhythm Sleep Disorders Market make the report investor’s guide.

Global Circadian Rhythm Sleep Disorders Market Scope: Inquire before buying

Global Circadian Rhythm Sleep Disorders Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 0.88 Bn.
Forecast Period 2023 to 2029 CAGR: 5.33% Market Size in 2029: US $ 1.28 Bn.
Segments Covered: by Disorder Delayed Sleep Phase Syndrome (DSPS) Advanced Sleep Phase Syndrome (ASPS) Irregular Sleep-Wake Disorder (ISWD) Shift Work Disorder Free-Running Type Jet Lag
by End User Home Care Settings Wellness Centers & Spa Sleep Testing Centers Specialty Clinics
by Treatment Type Healthy Lifestyle Changes Bright Light Therapy Melatonin
by Distribution Channel Institutional Sales Retail Sales
by Drugs Melatonin Modafinil Tasimelteon

Global Circadian Rhythm Sleep Disorders Market by Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Global Circadian Rhythm Sleep Disorders Market Key Players

1. Vanda Pharmaceuticals, Inc 2. Takeda Pharmaceutical Company Limited 3. VU University Medical Center, U.S. 4. Centers of Disease Control and Prevention 5. Verilux, Inc 6. The Sunbox Company 7. Carex Health 8. Northern Light Technologies 9. Beurer GmbH 10.Luminette 11.Koninklijke Philips N.V 12.Lanaform 13.Sunrise System 14.Samarit Medical AG 15.ResMed Inc 16.Fitbit, Inc 17.Natus Medical, Inc 18.SOMNOmedics GmbH 19.BMC Medical Co., Ltd 20.Activinsights Ltd Frequently Asked Questions: 1. Which region has the largest share in Global Circadian Rhythm Sleep Disorders Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Circadian Rhythm Sleep Disorders Market? Ans: The Global Market is growing at a CAGR of 5.33% during forecasting period 2023-2029. 3. What is scope of the Global Circadian Rhythm Sleep Disorders market report? Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Circadian Rhythm Sleep Disorders market? Ans: The important key players in the Global Market are – Vanda Pharmaceuticals, Inc, Takeda Pharmaceutical Company Limited, VU University Medical Center, U.S., Centers of Disease Control and Prevention, Verilux, Inc, The Sunbox Company, Carex Health, Northern Light Technologies, Beurer GmbH, Luminette, Koninklijke Philips N.V, Lanaform, Sunrise System, Samarit Medical AG, ResMed Inc, Fitbit, Inc, Natus Medical, Inc, SOMNOmedics GmbH, BMC Medical Co., Ltd, and Activinsights Ltd. 5. What is the study period of this market? Ans: The Global Market is studied from 2022 to 2029.
1. Global Circadian Rhythm Sleep Disorders Market: Research Methodology 2. Global Circadian Rhythm Sleep Disorders Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Circadian Rhythm Sleep Disorders Market 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Circadian Rhythm Sleep Disorders Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11. Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • South America 3.12 COVID-19 Impact 4. Global Circadian Rhythm Sleep Disorders Market Segmentation 4.1 Global Circadian Rhythm Sleep Disorders Market, by Disorder (2022-2029) • Delayed Sleep Phase Syndrome (DSPS) • Advanced Sleep Phase Syndrome (ASPS) • Irregular Sleep-Wake Disorder (ISWD) • Shift Work Disorder • Free-Running Type • Jet Lag 4.2 Global Circadian Rhythm Sleep Disorders Market, by End User (2022-2029) • Home Care Settings • Wellness Centers & Spa • Sleep Testing Centers • Specialty Clinics 4.3 Global Circadian Rhythm Sleep Disorders Market, by Treatment Type (2022-2029) • Healthy Lifestyle Changes • Bright Light Therapy • Melatonin 4.4 Global Circadian Rhythm Sleep Disorders Market, by Distribution Channel (2022-2029) • Institutional Sales • Retail Sales 4.5 Global Circadian Rhythm Sleep Disorders Market, by Drugs (2022-2029) • Melatonin • Modafinil • Tasimelteon 5. North America Circadian Rhythm Sleep Disorders Market(2022-2029) 5.1 North America Circadian Rhythm Sleep Disorders Market, by Disorder (2022-2029) • Delayed Sleep Phase Syndrome (DSPS) • Advanced Sleep Phase Syndrome (ASPS) • Irregular Sleep-Wake Disorder (ISWD) • Shift Work Disorder • Free-Running Type • Jet Lag 5.2 North America Circadian Rhythm Sleep Disorders Market, by End User (2022-2029) • Home Care Settings • Wellness Centers & Spa • Sleep Testing Centers • Specialty Clinics 5.3 North America Circadian Rhythm Sleep Disorders Market, by Treatment Type (2022-2029) • Healthy Lifestyle Changes • Bright Light Therapy • Melatonin 5.4 North America Circadian Rhythm Sleep Disorders Market, by Distribution Channel (2022-2029) • Institutional Sales • Retail Sales 5.5 North America Circadian Rhythm Sleep Disorders Market, by Drugs (2022-2029) • Melatonin • Modafinil • Tasimelteon 5.6 North America Circadian Rhythm Sleep Disorders Market, by Country (2022-2029) • United States • Canada • Mexico 6. Europe Circadian Rhythm Sleep Disorders Market (2022-2029) 6.1. European Circadian Rhythm Sleep Disorders Market, by Disorder (2022-2029) 6.2. European Circadian Rhythm Sleep Disorders Market, by End User (2022-2029) 6.3. European Circadian Rhythm Sleep Disorders Market, by Treatment Type (2022-2029) 6.4. European Circadian Rhythm Sleep Disorders Market, by Distribution Channel (2022-2029) 6.5. European Circadian Rhythm Sleep Disorders Market, by Drugs (2022-2029) 6.6. European Circadian Rhythm Sleep Disorders Market, by Country (2022-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Circadian Rhythm Sleep Disorders Market (2022-2029) 7.1. Asia Pacific Circadian Rhythm Sleep Disorders Market, by Disorder (2022-2029) 7.2. Asia Pacific Circadian Rhythm Sleep Disorders Market, by End User (2022-2029) 7.3. Asia Pacific Circadian Rhythm Sleep Disorders Market, by Treatment Type (2022-2029) 7.4. Asia Pacific Circadian Rhythm Sleep Disorders Market, by Distribution Channel (2022-2029) 7.5. Asia Pacific Circadian Rhythm Sleep Disorders Market, by Drugs (2022-2029) 7.6. Asia Pacific Circadian Rhythm Sleep Disorders Market, by Country (2022-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Circadian Rhythm Sleep Disorders Market (2022-2029) 8.1 Middle East and Africa Circadian Rhythm Sleep Disorders Market, by Disorder (2022-2029) 8.2. Middle East and Africa Circadian Rhythm Sleep Disorders Market, by End User (2022-2029) 8.3. Middle East and Africa Circadian Rhythm Sleep Disorders Market, by Treatment Type (2022-2029) 8.4. Middle East and Africa Circadian Rhythm Sleep Disorders Market, by Distribution Channel (2022-2029) 8.5. Middle East and Africa Circadian Rhythm Sleep Disorders Market, by Drugs (2022-2029) 8.6. Middle East and Africa Circadian Rhythm Sleep Disorders Market, by Country (2022-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Circadian Rhythm Sleep Disorders Market (2022-2029) 9.1. South America Circadian Rhythm Sleep Disorders Market, by Disorder (2022-2029) 9.2. South America Circadian Rhythm Sleep Disorders Market, by End User (2022-2029) 9.3. South America Circadian Rhythm Sleep Disorders Market, by Treatment Type (2022-2029) 9.4. South America Circadian Rhythm Sleep Disorders Market, by Distribution Channel (2022-2029) 9.5. South America Circadian Rhythm Sleep Disorders Market, by Drugs (2022-2029) 9.6. South America Circadian Rhythm Sleep Disorders Market, by Country (2022-2029) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1 Vanda Pharmaceuticals, Inc 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2 Takeda Pharmaceutical Company Limited 10.3 VU University Medical Center, U.S. 10.4 Centers of Disease Control and Prevention 10.5 Verilux, Inc 10.6 The Sunbox Company 10.7 Carex Health 10.8 Northern Light Technologies 10.9 Beurer GmbH 10.10 Luminette 10.11 Koninklijke Philips N.V 10.12 Lanaform 10.13 Sunrise System 10.14 Samarit Medical AG 10.15 ResMed Inc 10.16 Fitbit, Inc 10.17 Natus Medical, Inc 10.18 SOMNOmedics GmbH 10.19 BMC Medical Co., Ltd 10.20 Activinsights Ltd

About This Report

Report ID 106659
Category Healthcare
Published Date September 2023
Updated Date
  • INQUIRE BEFORE BUYING